Patents Assigned to GA Generic Assays GmbH
  • Patent number: 11549952
    Abstract: The invention relates to an in vitro method for the diagnosis of acute pancreatitis (AP) in a subject by detection of Glycoprotein 2 isoform alpha (GP2a) protein.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: January 10, 2023
    Assignee: GA GENERIC ASSAYS GMBH
    Inventor: Dirk Roggenbuck
  • Patent number: 11340235
    Abstract: The invention relates to a method for binding or capturing autoantibodies directed to various Glycoprotein 2 (GP2) isoforms. In particular the invention provides an in vitro method for the diagnosis of an autoimmune disorder by the detection of autoantibodies that bind one or more isoforms of GP2. The invention is characterized by the provision of multiple isoforms of GP2 as autoantibody targets and encompasses the practical utilization of the finding that the isoform specificity of anti-GP2 autoantibodies enables determination of particular autoimmune diseases. The invention also provides a system and kit developed for carrying out the claimed method. The present invention is useful for determining whether a sample from an individual comprises autoantibodies associated with an autoimmune disease, and for differentiating between multiple autoimmune diseases that exhibit similar symptoms, such as Celiac disease (CeD), Crohn's disease (CD), primary sclerosing cholangitis (PSC), and/or ulcerative colitis (UC).
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: May 24, 2022
    Assignee: GA GENERIC ASSAYS GMBH
    Inventor: Dirk Roggenbuck
  • Patent number: 11238581
    Abstract: Disclosed are a method for computer-assisted evaluation of biomarkers in a tissue sample as well as a corresponding system and computer program. The method includes the following steps: providing an image of the tissue sample in which cell nuclei of the tissue as well as biomarkers are represented, automatically determining for a plurality of locations or regions within the image a blood vessel probability that represents a probability that the image at the corresponding location or region represents a blood vessel, automatically determining an assumed blood vessel location within the image based on a distribution of blood vessel probability with respect to the locations or regions within the image, automatically selecting biomarkers represented in the image at locations outside the assumed blood vessel location but within a threshold distance from the assumed blood vessel location, and automatically evaluating the selected biomarkers.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: February 1, 2022
    Assignees: Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts, Brandenburgische Technische Universität Cottbus-Senftenberg, GA Generic Assays GmbH
    Inventors: Cläre Von Neubeck, Rico Hiemann, Alexey Elimport
  • Publication number: 20190219596
    Abstract: The invention relates to an in vitro method for the diagnosis of acute pancreatitis (AP) in a subject by detection of Glycoprotein 2 isoform alpha (GP2a) protein.
    Type: Application
    Filed: September 26, 2017
    Publication date: July 18, 2019
    Applicant: GA GENERIC ASSAYS GMBH
    Inventor: Dirk Roggenbuck
  • Patent number: 8058019
    Abstract: The invention relates to a method for the detection of antibodies from body fluids via immune reaction with GP2 from pancreatic zymogenic granules, immunoreactive sequences or analogs thereof, excluding tissue sections.
    Type: Grant
    Filed: January 28, 2008
    Date of Patent: November 15, 2011
    Assignee: GA Generic Assays GmbH
    Inventor: Dirk Roggenbuck
  • Publication number: 20100184662
    Abstract: The invention relates to a method for the detection of antibodies from body fluids via immune reaction with GP2 from pancreatic zymogenic granules, immunoreactive sequences or analogs thereof, excluding tissue sections.
    Type: Application
    Filed: January 28, 2008
    Publication date: July 22, 2010
    Applicant: GA GENERIC ASSAYS GMBH
    Inventor: Dirk Roggenbuck